Ampio Pharmaceuticals, Inc. (NYSE: AMPE) Starts Presentation at LD Micro Main Event
Ampio Pharmaceuticals (NYSE MKT: AMPE) is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The company is developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability. For more information, visit the company’s website at http://ampiopharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news…
